Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Learn how online tools can help you efficiently find investment opportunities. Simplify your investment search with technology.
22,540 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
As Advansix positions itself in a volatile chemical market, understanding advansix (asix) 2025 earnings becomes essen...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
Small modular reactors could redefine electricity costs and energy security. This guide breaks down the investment th...
An investor group disclosed a $3.5 million stake in Avantor as the stock slipped more than half. This article breaks ...
In early 2026, Tutor Perini faced a mix of growth opportunities and project-level headwinds. This article breaks down...
This deep-dive breaks down accelerant (arx) 2026 earnings, translating the Q1 transcript into actionable takeaways. L...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
As Life360 maps its path into 2025, investors face a pivotal question: will the life360 (lif) 2025 earnings story hin...
As AI fuels energy needs, NuScale’s small modular reactors offer a faster, scalable path to cleaner power. This guide...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Constellation Energy plunged today after a mix of macro moves and strategic shifts. This guide breaks down the factor...